NCT01736059View on ClinicalTrials.gov

Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Non-exudative Age-related Macular DegenerationDiabetic RetinopathyRetina Vein OcclusionRetinitis PigmentosaHereditary Macular Degeneration
Interventions
DRUG

CD34+ bone marrow stem cells intravitreal

Trial Locations (1)

95817

University of California Davis, Sacramento

All Listed Sponsors
lead

University of California, Davis

OTHER